Jeff Yass’s First Tracks Biotherapeutics TRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding TRAX
Jeff Yass's TRAX Position: Q3 2026 in Review
Jeff Yass increased its First Tracks Biotherapeutics (TRAX) stake by 88% in Q3 2026, buying an estimated $725K and bringing the position to 39,691 shares worth $1.41M. The position accounts for ﹤0.01% of the portfolio, ranked #7136.
Jeff Yass first reported a position in TRAX in Q2 2026 and has held it in 2 quarters since. 182 funds tracked by Wall St. Rank hold TRAX as of Q3 2026.
- Jeff Yass held 39,691 shares of First Tracks Biotherapeutics worth $1.41M as of Q3 2026.
- Jeff Yass bought 18,562 First Tracks Biotherapeutics shares in Q3 2026, an estimated $725K.
- First Tracks Biotherapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #7136 holding.
- Jeff Yass first reported a position in First Tracks Biotherapeutics in Q2 2026 and has held it in 2 quarters since.
- 182 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.